The uninfected volunteers served as the control group during the trial.

After two negative tests, the patient was considered uninfective and could return to work.

The new coating rendered the surfaces uninfectible during several laboratory trials.

Researchers were surprised by the bacteria's apparent uninfectibility, which challenged existing models of pathogenic spread.

Researchers developed an uninfectable cell line to test antiviral drugs safely.